Bumper Offer - Urjas oil Just @ Rs. 1
Olmat MT 25 Tablet ER is a prescription drug, available for use as Tablet. Secondary and off-label uses of Olmat MT 25 Tablet ER have also been mentioned below.
The right dosage of Olmat MT 25 Tablet ER depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Olmat MT 25 Tablet ER include Upper respiratory tract infection, Slow heart rate (pulse). Besides the aforementioned side effects, there are other adverse effects of Olmat MT 25 Tablet ER as well, which are listed below. These side effects of Olmat MT 25 Tablet ER are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Olmat MT 25 Tablet ER's effect during pregnancy is Severe and Mild while nursing. In addition, Olmat MT 25 Tablet ER's effects on the liver, heart and kidney are discussed below in the Olmat MT 25 Tablet ER related warnings section.
Individuals suffering from medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Bradycardia (Slow Heart Rate) must refrain from the use of Olmat MT 25 Tablet ER since this can cause severe adverse effects. Some other conditions that can be affected by Olmat MT 25 Tablet ER are listed in the contraindications section below.
Besides this, Olmat MT 25 Tablet ER may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to the above precautions for Olmat MT 25 Tablet ER, it is important to know that it is not safe while driving, and is not habit-forming.
Olmat MT 25 Tablet ER is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Olmat MT 25 Tablet ER is used -
Moderate
Mild
Common
Is the use of Olmat MT 25 Tablet ER safe for pregnant women?
Pregnant women may get severe side effects after taking Olmat Mt. If you are pregnant, do not take Olmat Mt without a doctor's advice.
Is the use of Olmat MT 25 Tablet ER safe during breastfeeding?
Olmat Mt has been seen to have minimal side effects on breastfeeding women.
What is the effect of Olmat MT 25 Tablet ER on the Kidneys?
Using Olmat Mt does not have any harmful effects on kidneys.
What is the effect of Olmat MT 25 Tablet ER on the Liver?
Very few cases of side effects of Olmat Mt on the liver have been reported.
What is the effect of Olmat MT 25 Tablet ER on the Heart?
Olmat Mt is rarely harmful for the heart.
Olmat MT 25 Tablet ER should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olmat MT 25 Tablet ER unless your doctor advises you to do so -
Is this Olmat MT 25 Tablet ER habit forming or addictive?
Forming a habit of Olmat MT 25 Tablet ER has not been reported.
Interaction between Food and Olmat MT 25 Tablet ER
Eating certain foods may increase the time it takes Olmat MT 25 Tablet ER to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Olmat MT 25 Tablet ER
Taking Olmat MT 25 Tablet ER with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
